G. Assche

发表

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management.

C. O'Morain, D. Hommes, S. Travis, 2010, Journal of Crohn's & colitis.

Long-term outcome of treatment with infliximab in 614 patients with Crohn’s disease: results from a single-centre cohort

K. Van Steen, P. Rutgeerts, S. Vermeire, 2008, Gut.

Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target

T. Murdoch, M. Silverberg, W. Bemelman, 2015, The American Journal of Gastroenterology.

Laboratory markers in IBD: useful, magic, or unnecessary toys?

P. Rutgeerts, S. Vermeire, G. Van Assche, 2006, Gut.

Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelines.

Jeroen A. W. Tielbeek, J. Stoker, C. Matos, 2013, Journal of Crohn's & colitis.

[Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management (Spanish version)].

S. Travis, M. Sans, J. Lindsay, 2015, Revista de gastroenterologia de Mexico.

Long-term safety of infliximab for the treatment of inflammatory bowel disease: a single-centre cohort study

P. Rutgeerts, S. Vermeire, M. Ferrante, 2007, Gut.

[Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 3: Special situations (Spanish version)].

G. Rogler, S. Travis, P. Gionchetti, 2015, Revista de gastroenterologia de Mexico.

Involvement of interleukin 18 in Crohn's disease: evidence from in vitro analysis of human gut inflammatory cells and from experimental colitis models

P. Rutgeerts, G. Van Assche, J. Ceuppens, 2004, Clinical and experimental immunology.

leukoencephalopathy? for elevated risk of progressive multifocal treated with immunosuppression: can we screen JC viral loads in patients with Crohn's disease

S. Vermeire, J. Dillner, M. Noman, 2008 .

Epithelioid granulomas, pattern recognition receptors, and phenotypes of Crohn’s disease

P. van Eyken, P. Rutgeerts, S. Vermeire, 2005, Gut.

Dysplasia and colorectal cancer in inflammatory bowel disease: a result of inflammation or an intrinsic risk?

P. Rutgeerts, S. Vermeire, G. Van Assche, 2008, Acta gastro-enterologica Belgica.

[Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 3: Special situations (Spanish version)].

P. Gionchetti, S. Danese, B. Oldenburg, 2015, Revista de gastroenterologia de Mexico.